Skip to main content
. 2011 Aug 8;589(Pt 19):4671–4679. doi: 10.1113/jphysiol.2011.216218

Figure 1. Percentage maximal skin blood flow (SkBF) prior to and following 45 min of infusion of either ET-A receptor antagonist (BQ-123) or ET-B receptor antagonist (BQ-788) via microdialysis in women with (PCOS) and without (Control) polycystic ovary syndrome.

Figure 1

*Different between PCOS and Control. †Different between pre- and post-antagonist infusion. Data are presented as means ± SEM.